Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunilla Kumlien

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Transplant Immunology|June 30, 2011
Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantationAnna Nordlander, Michael Uhlin, Olle Ringdén, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 8, 2005
ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximabGunnar Tydén, Gunilla Kumlien, Helena Genberg, et al.
Xenotransplantation|April 21, 2006
The Stockholm experience with ABO-incompatible kidney transplantations without splenectomyGunnar Tydén, Gunilla Kumlien, Helena Genberg, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 31, 2012
Intentional ABO-incompatible heart transplantation: a case report of 2 adult patientsGunnar Tydén, Inger Hagerman, Karl-Henrik Grinnemo, et al.
Transplantation|May 15, 2007
Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantationsGunnar Tydén, Johannes Donauer, Jonas Wadström, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantationMats Remberger, Gunilla Kumlien, Johan Aschan, et al.
Scandinavian Journal of Infectious Diseases|June 19, 2002
Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donorsPer Ljungman, Kajsa Larsson, Gunilla Kumlien, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center studyMats Remberger, Malin Ackefors, Sofia Berglund, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Transplant Immunology|June 30, 2011
Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantationAnna Nordlander, Michael Uhlin, Olle Ringdén, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 8, 2005
ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximabGunnar Tydén, Gunilla Kumlien, Helena Genberg, et al.
Xenotransplantation|April 21, 2006
The Stockholm experience with ABO-incompatible kidney transplantations without splenectomyGunnar Tydén, Gunilla Kumlien, Helena Genberg, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 31, 2012
Intentional ABO-incompatible heart transplantation: a case report of 2 adult patientsGunnar Tydén, Inger Hagerman, Karl-Henrik Grinnemo, et al.
Transplantation|May 15, 2007
Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantationsGunnar Tydén, Johannes Donauer, Jonas Wadström, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantationMats Remberger, Gunilla Kumlien, Johan Aschan, et al.
Scandinavian Journal of Infectious Diseases|June 19, 2002
Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donorsPer Ljungman, Kajsa Larsson, Gunilla Kumlien, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center studyMats Remberger, Malin Ackefors, Sofia Berglund, et al.
Pageof 2